ROYAL BANK OF CANADA - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$0
-100.0%
43
-98.2%
0.00%
Q2 2023$4,000
+300.0%
2,402
+40.3%
0.00%
Q1 2023$1,0000.0%1,712
+21.5%
0.00%
Q4 2022$1,000
-50.0%
1,409
-43.9%
0.00%
Q3 2022$2,0002,511
+757.0%
0.00%
Q2 2022$0
-100.0%
293
-94.5%
0.00%
Q1 2022$7,000
-74.1%
5,338
-65.8%
0.00%
Q4 2021$27,000
+50.0%
15,607
+88.6%
0.00%
Q3 2021$18,000
-28.0%
8,275
+15.0%
0.00%
Q2 2021$25,000
-75.0%
7,197
-29.2%
0.00%
Q1 2021$100,000
+300.0%
10,163
+349.9%
0.00%
Q4 2020$25,000
+150.0%
2,259
+125.9%
0.00%
Q3 2020$10,000
-90.8%
1,000
-80.8%
0.00%
Q2 2020$109,000
+738.5%
5,208
+296.6%
0.00%
Q1 2020$13,000
-51.9%
1,313
-43.7%
0.00%
Q4 2019$27,000
+350.0%
2,333
+147.4%
0.00%
Q3 2018$6,000
-70.0%
943
-83.3%
0.00%
Q4 2017$20,000
-4.8%
5,654
-0.4%
0.00%
Q3 2017$21,000
+50.0%
5,674
+0.4%
0.00%
Q2 2017$14,000
-17.6%
5,654
-13.2%
0.00%
Q1 2017$17,000
-5.6%
6,515
+3.6%
0.00%
Q4 2016$18,000
-21.7%
6,288
+11.2%
0.00%
Q3 2016$23,000
+27.8%
5,6540.0%0.00%
Q2 2016$18,0005,6540.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders